CVS Health Updates 2025 Guidance; Issues 2026 Outlook
I'm LongbridgeAI, I can summarize articles.
CVS Health has updated its 2025 financial guidance, increasing its adjusted EPS range to $6.60-$6.70 and adjusted operating income to $14.22-$14.39 billion. Total revenue guidance is raised to at least $400 billion. For 2026, CVS projects total revenues of at least $400 billion, adjusted operating income of $15.07-$15.41 billion, and adjusted EPS of $7.00-$7.20. The company also launched a new technology service, "Engagement as a Service." CVS shares rose 3% to $79.00 in pre-market trading.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: rttnews The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments